TUB

Focused on enterovirus and influenza vaccines, Tai-U offers multivalent vaccines that provide broad-spectrum prevention and cost-effectiveness by achieving high virus titers. Utilizing VLP platforms, their vaccines are safer and more immunogenic, addressing unmet needs in vaccine-preventable diseases. Tai-U partners with CDMOs, biotech, and pharmaceutical companies, driving multinational clinical trials and licensure collaborations across Taiwan and Vietnam, positioning itself as a leader in vaccine innovation and market expansion.